Cybin (CYBN) Competitors

Cybin (NYSE:CYBN) and uniQure (NASDAQ:QURE) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Do institutionals and insiders hold more shares of CYBN or QURE?

17.9% of Cybin shares are held by institutional investors. Comparatively, 78.8% of uniQure shares are held by institutional investors. 15.0% of Cybin shares are held by insiders. Comparatively, 4.7% of uniQure shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the media refer more to CYBN or QURE?

In the previous week, Cybin had 2 more articles in the media than uniQure. MarketBeat recorded 4 mentions for Cybin and 2 mentions for uniQure. Cybin's average media sentiment score of 1.08 beat uniQure's score of 0.96 indicating that Cybin is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cybin	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
uniQure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend CYBN or QURE?

Cybin currently has a consensus target price of $138.00, suggesting a potential upside of 1,411.50%. uniQure has a consensus target price of $33.88, suggesting a potential upside of 141.10%. Given Cybin's higher possible upside, equities research analysts plainly believe Cybin is more favorable than uniQure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cybin	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
uniQure	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

Is CYBN or QURE more profitable?

Cybin has a net margin of 0.00% compared to uniQure's net margin of -837.80%. Cybin's return on equity of -52.17% beat uniQure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cybin	N/A	-52.17%	-50.52%
uniQure	-837.80%	-188.82%	-32.17%

Which has more risk & volatility, CYBN or QURE?

Cybin has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, uniQure has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Which has stronger earnings and valuation, CYBN or QURE?

Cybin has higher earnings, but lower revenue than uniQure. uniQure is trading at a lower price-to-earnings ratio than Cybin, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cybin	N/A	N/A	-$57.88M	-$6.66	-1.37
uniQure	$15.84M	43.23	-$308.48M	-$4.96	-2.83

Does the MarketBeat Community believe in CYBN or QURE?

uniQure received 641 more outperform votes than Cybin when rated by MarketBeat users. However, 100.00% of users gave Cybin an outperform vote while only 70.67% of users gave uniQure an outperform vote.

Company	Underperform	Outperform
Cybin	Outperform Votes 12 100.00%	Underperform Votes No Votes
uniQure	Outperform Votes 653 70.67%	Underperform Votes 271 29.33%

Summary

Cybin beats uniQure on 9 of the 16 factors compared between the two stocks.